orm_mar_apr-2025 - 10

READER'S CHOICE: OR AM TOP READ STORIES
Nurses top Gallup's most trusted
professions list, other roles drop
Gallup's 2024 poll of the most trusted
professions reaffirms nurses as the
most trusted group, with 75% of Americans
rating their honesty and ethics as
" high " or " very high, " the organization
announced January 13.
According to the article, nurses have
held the top spot nearly every year since
their inclusion in 1999. Medical doctors
also `rank` high, but their trust rating
has fallen significantly, dropping from a
pandemic high of 77% in 2020 to just
53% in 2024-their lowest level since
the mid-1990s. Pharmacists, while still
among the most trusted, have also experienced
declines in trust since their
pandemic peak.
Although healthcare professions in
general saw a surge in trust during the
early pandemic years, they have largely
returned to or fallen below pre-pandemic
levels. This trend reflects a broader
decline in public trust tied to reduced
confidence in US institutions. Social
and political dynamics, including polarized
responses to public health measures
and ongoing challenges within the
healthcare system, may contribute to
this erosion, Gallup reports.
-https://news.gallup.com/
poll/655106/americans-ratings-professions-stay-historically-low.aspx
AI
shows promise for addressing
nursing workforce challenges
Although the role of artificial intelligence
(AI) is evolving, early applications show
significant potential to address challenges
with burnout, staffing shortages,
and high patient-to-nurse ratios, according
to a January 10 article in Medscape.
Offering a broad overview of the state
of AI in nursing, complete with expert
testimony and examples, the article
notes that nurses are overall optimistic
about the technology. In a recent
survey, two-thirds expressed that AI
could improve workloads and patient
outcomes, citing value in areas such as
medication management, patient education,
and clinical decision support.
However, 36% of nurses report a lack
10
OR Manager | Mar/Apr 2025
Our free daily eLetter gives a snapshot
of the day's most important
news first thing in the morning!
Register at www.ormanager.com/
subscribe-or-am/.
of knowledge about how to use AI tools,
highlighting the need for education and
training.
Administrative tasks-which are estimated
to occupy as much as 15% of
nurses' shifts-are a key target for AI,
Medscape reports. Tools such as transcription
software and device integration
have shown promise in reducing the
time spent on documentation. Major
health systems, including Mass General
Brigham, Baptist Health, and Stanford
Health Care, are deploying AI-powered
tools for documentation.
Concerns about ethical use, quality
of care, and equity in AI adoption remain
prevalent. As detailed in the article, critics
emphasize that AI must align with
the nursing profession's core values
and ethical standards. Efforts to involve
nurses in AI tool development and deployment
also are seen as critical for
successful integration and acceptance,
as is addressing equity issues.
-www.medscape.com/viewarticle/aiand-art-nursing-2025a10000jg
Expansive
study highlights
GLP-1 risks, potential
Known for managing Type 2 diabetes
and promoting weight loss, GLP-1 drugs
like Ozempic and Wegovy may also reduce
the risks of numerous other conditions,
including Alzheimer's, substance
use disorders, and certain cancers, according
to an article published in Fortune
on January 20.
Led by the Veterans Affairs St. Louis
Health Care System and published in
Interested in getting news like this
delivered to your email each day?
Nature, the research analyzed data from
nearly 2 million individuals with Type 2
diabetes-the largest investigation of
GLP-1 drugs to date, Fortune reports.
Of that total, about 215,000 individuals
used GLP-1s. The rest received other
diabetes treatments. Over a median follow-up
of 3.5 years, GLP-1 users experienced
a 24% reduction in risks for 42
health conditions, including psychotic
disorders, neurodegenerative diseases,
infections, liver cancer, and respiratory
issues. However, GLP-1 use increased
risks for 19 conditions, such as kidney
stones and low blood pressure.
The study revealed particularly intriguing
neurological effects, such as reduced
risks of substance use disorders
and Alzheimer's disease. As detailed
in the article, researchers hypothesize
that GLP-1 drugs may suppress brain
centers responsible for cravings, contributing
to these benefits. The suggestion
that GLP-1s have a broad impact on
brain health is also sparking interest in
ongoing trials for neurodegenerative diseases.
Beyond the brain, GLP-1 drugs
positively influence inflammation, oxidative
stress, and metabolic health-factors
underpinning many chronic conditions,
Fortune reports.
Questions remain about
long-term
safety and whether benefits persist
after discontinuing GLP-1s. According
to the article, side effects include pancreatitis,
arthritis, and gastrointestinal
issues. High costs and adherence challenges
also limit widespread use; nearly
60% of US patients discontinue these
drugs within 12 weeks.
-www.fortune.com/well/article/
ozempic-glp1-study-lower-risk-42-healthconditions-heart-attack-alzheimers/
EHR-integrated
clinical decision
support reduces unneeded tests
An EHR-integrated closed-loop clinical
decision support system (CDSS) significantly
reduced unnecessary preoperative
testing, improved patient safety,
and significantly reduced costs across
two hospitals in Madrid, Spain. As detailed
in a study published January 3 in
npj Digital Medicine, this system demwww.ormanager.com
https://www.ormanager.com/subscribe-or-am/ https://news.gallup.com/poll/655106/americans-ratings-professions-stay-historically-low.aspx https://www.medscape.com/viewarticle/ai-and-art-nursing-2025a10000jg?form=fpf https://fortune.com/well/article/ozempic-glp1-study-lower-risk-42-health-conditions-heart-attack-alzheimers/
orm_mar_apr-2025

Table of Contents for the Digital Edition of orm_mar_apr-2025
